Thomas H. Keller - Concepedia

Author

Thomas H. Keller

Also Known As

Clive McCarthy, Keller, Thomas, Keller, Thomas H, Keller, Thomas H., T H Keller, T KELLER, T. H. KELLER, T. KELLER, T. Keller, THOMAS KELLER

200

Publications

9.1K

Citations

H-Index

129

Concepts

All Affiliations

Novartis (Singapore)Experimental Drug Development Centre Agency for Science, Technology and Research Novartis (Switzerland)Novartis Institutes for BioMedical Research

About

Thomas H. Keller is an author at Novartis (Singapore) specializing in medicine, biochemistry, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	33	49	5.6K
2	Natural Sciences	23	35	2.9K
3	Engineering	5	5	78
4	Health Sciences	3	3	659
5	Public Health	1	1	92

Thomas H. Keller

Publications

8.4K

Citations

H-Index

Page 1

	Year	Citations
Spiroindolones, a Potent Compound Class for the Treatment of Malaria Matthias Rottmann, Case W. McNamara, Bryan K. S. Yeung, Science Medicinal ChemistryPharmaceutical ChemistryPharmaceutical ScienceBiochemistryAntiparasitic Agent	2010	1.2K
PA-824 Kills Nonreplicating <i>Mycobacterium tuberculosis</i> by Intracellular NO Release Ramandeep Singh, Ujjini H. Manjunatha, Helena I. Boshoff, Science Bioorganic ChemistryNitric OxideTuberculosis PreventionInnate Immune SystemDrug Resistance	2008	626
Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus P. Erbel, Nikolaus Schiering, A. D’Arcy, Nature Structural & Molecular Biology Virus StructureViral ReplicationPathogenesisMolecular BiologyVirology	2006	567
Spirotetrahydro β-Carbolines (Spiroindolones): A New Class of Potent and Orally Efficacious Compounds for the Treatment of Malaria Bryan K. S. Yeung, Bin Zou, Matthias Rottmann, Journal of Medicinal Chemistry	2010	420
An adenosine nucleoside inhibitor of dengue virus Zheng Yin, Yen‐Liang Chen, Wouter Schul, Proceedings of the National Academy of Sciences Dengue VirusMolecular VirologyMedicineImmunologyAntiviral Therapy	2009	389
Wnt addiction of genetically defined cancers reversed by PORCN inhibition Babita Madan, Zhanbo Ke, Nathan Harmston, Oncogene Porcn InhibitionPathologyWnt AddictionAvailable Porcn InhibitorTumor Biology	2015	339
A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy Kévin Pethe, Patrícia Carvalho de Sequeira, Sanjay Agarwalla, Nature Communications Bioorganic ChemistryTuberculosis PreventionBacteriologyMolecular BiologyVivo Efficacy	2010	303
A Small-Molecule Dengue Virus Entry Inhibitor Qingyin Wang, Sejal Patel, Eric Vangrevelinghe, Antimicrobial Agents and Chemotherapy	2009	206
Small Molecule Inhibitors That Selectively Block Dengue Virus Methyltransferase Siew Pheng Lim, Louis Sebastian Sonntag, Christian G. Noble, Journal of Biological Chemistry	2010	185
Peptide inhibitors of dengue virus NS3 protease. Part 1: Warhead Zheng Yin, Sejal Patel, Weiling Wang, Bioorganic & Medicinal Chemistry Letters ImmunologyAntiviral Drug DevelopmentVirologyAntiviral DrugViral Structural Protein	2005	157

Page 1